Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SNDQ vs GSK✓SelectedUSD · GSKSNDQ vs GSK performance historyLatest closeAs of+31.64%11/20
Stock and ETF performance explorer

SNDQ vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-82.8%
GSK return
-12.3%
Excess return
-70.4%
Maximum drawdown
-96.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+31.6%-0.1%+31.8%+32.0%
7D+75.8%-5.3%+81.2%+100.6%
30D+194.1%-3.7%+197.7%+223.7%
3M+220.0%-7.3%+227.2%+297.2%
6M-49.5%-4.2%-45.2%-35.6%
All-82.8%-12.3%-70.4%-73.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling